InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Enveric Biosciences, Inc.

ENVB Clue Score35
United States Fiscal year ends December CIK 0000890821
$1.45 -4.61% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.45 −24.87% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue36.1Operating income−5.4Net income−2.8EPS, diluted−0.21Fiscal year 2017Revenue48.6 +34.4%Operating income−10.9Net income−9.1EPS, diluted−0.75Fiscal year 2018Revenue43.0 −11.5%Operating income−7.1Net income−16.9EPS, diluted−20.47Fiscal year 2019Revenue39.9 −7.2%Operating income−2.3Net income−2.4EPS, diluted−2.83Fiscal year 2020Operating income−5.6Net income−6.9Fiscal year 2021Operating income−64.6Net income−49.0Fiscal year 2022Operating income−27.4Net income−18.5EPS, diluted−13.00Fiscal year 2023Operating income−16.4Net income−17.3EPS, diluted−121.29Fiscal year 2024Operating income−9.6Net income−9.6EPS, diluted−228.48Fiscal year 2025Operating income−8.8Net income−8.8EPS, diluted−36.24
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 36.1 48.6 43.0 39.9 n/a n/a n/a n/a n/a n/a
Growth +34.4% −11.5% −7.2%
Operating income −5.4 −10.9 −7.1 −2.3 −5.6 −64.6 −27.4 −16.4 −9.6 −8.8
Net income −2.8 −9.1 −16.9 −2.4 −6.9 −49.0 −18.5 −17.3 −9.6 −8.8
Growth
EPS, diluted −0.21 −0.75 −20.47 −2.83 n/a n/a −13.00 −121.29 −228.48 −36.24

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin19.2%Operating margin−14.9%Net margin−7.7%Fiscal year 2017Gross margin21.1%Operating margin−22.4%Net margin−18.7%Fiscal year 2018Gross margin20.9%Operating margin−16.6%Net margin−39.3%Fiscal year 2019Gross margin20.4%Operating margin−5.8%Net margin−6.0%Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 19.2% 21.1% 20.9% 20.4% n/a n/a n/a n/a n/a n/a
Operating margin −14.9% −22.4% −16.6% −5.8% n/a n/a n/a n/a n/a n/a
Net margin −7.7% −18.7% −39.3% −6.0% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−2.7Fiscal year 2017Operating cash flow−2.7Fiscal year 2018Operating cash flow−2.6Fiscal year 2019Operating cash flow−0.6Fiscal year 2020Operating cash flow−3.9Fiscal year 2021Operating cash flow−11.5Capital expenditure−0.2Free cash flow−11.6Fiscal year 2022Operating cash flow−17.1Capital expenditure−0.6Free cash flow−17.7Fiscal year 2023Operating cash flow−14.1Capital expenditure−0.0Free cash flow−14.1Fiscal year 2024Operating cash flow−7.7Fiscal year 2025Operating cash flow−8.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −2.7 −2.7 −2.6 −0.6 −3.9 −11.5 −17.1 −14.1 −7.7 −8.1
Capital expenditure n/a n/a n/a n/a n/a −0.2 −0.6 −0.0 n/a n/a
Free cash flow n/a n/a n/a n/a n/a −11.6 −17.7 −14.1 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash1.4Total debt1.9Net cash (debt)−0.6Shareholders’ equity11.7Debt to equity0.17Fiscal year 2017Cash4.9Total debt1.9Net cash (debt)3.0Shareholders’ equity19.4Debt to equity0.10Fiscal year 2018Cash1.4Total debt0.0Net cash (debt)1.4Shareholders’ equity−0.1Fiscal year 2019Cash0.4Total debt0.7Net cash (debt)−0.3Shareholders’ equity−1.8Fiscal year 2020Cash1.6Shareholders’ equity3.4Fiscal year 2021Shareholders’ equity22.3Fiscal year 2022Shareholders’ equity14.7Fiscal year 2023Shareholders’ equity2.0Fiscal year 2024Shareholders’ equity1.6Fiscal year 2025Shareholders’ equity4.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 1.4 4.9 1.4 0.4 1.6 n/a n/a n/a n/a n/a
Total debt 1.9 1.9 0.0 0.7 n/a n/a n/a n/a n/a n/a
Net cash (debt) −0.6 3.0 1.4 −0.3 n/a n/a n/a n/a n/a n/a
Shareholders’ equity 11.7 19.4 −0.1 −1.8 3.4 22.3 14.7 2.0 1.6 4.2
Debt to equity 0.17 0.10 n/a n/a n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
19.2% 21.1% 20.9% 20.4% n/a n/a n/a n/a n/a n/a
−14.9% −22.4% −16.6% −5.8% n/a n/a n/a n/a n/a n/a
−18.1% −23.6% −24.5% −13.1% n/a n/a n/a n/a n/a n/a
−7.7% −18.7% −39.3% −6.0% n/a n/a n/a n/a n/a n/a
Spending
0.2% n/a n/a n/a n/a n/a n/a n/a n/a n/a
25.9% 38.1% 25.1% 5.8% n/a n/a n/a n/a n/a n/a
Returns
−23.8% −46.7% n/a n/a −201.0% −219.6% −125.9% −883.9% −601.1% −210.0%
−7.0% −17.4% −57.0% −2,215.9% −167.6% −183.3% −94.5% −402.1% −310.6% −172.1%
Balance and payout
0.17 0.10 n/a n/a n/a n/a n/a n/a n/a n/a
70.5% 62.7% 63.7% 1,765.2% 16.6% 16.5% 20.4% n/a n/a n/a